Background and Objectives: Hepatitis C virus (HCV) infection is a common cause of cirrhosis worldwide, leading to significant economic and social burdens. Approximately 170 million people (3% of the population) are infected with HCV, with the risk of developing complications such as cirrhosis and hepatocellular carcinoma. In the United States, HCV is the main cause of liver cirrhosis, accounting for 26% of cases. Recent studies have shown an increase in the proportion of HCV-related liver cirrhosis. Materials and Methods: A total of 102 patients with chronic hepatitis C in the reactivation phase from the Atyrau and Aktobe regional hepatology centers, who had not previously received antiviral therapy, were examined. A control group, matched by gender and age, included 127 practically healthy individuals of Kazakh nationality. All patients underwent a comprehensive examination, which included a complete blood count, a biochemical blood analysis and PCR for HCV. Venous blood samples were taken from all subjects for molecular genetic analysis. Genotyping of TLR3 polymorphism (rs5743312, rs5743305, rs3775291, rs5743311, rs1879026) was performed using real-time PCR. Thes study is a case control study. Results: In patients with cirrhosis of the liver resulting from chronic hepatitis C (HCV), the results of biochemical analysis were statistically significantly higher than in patients with HCV without liver cirrhosis: the levels of total bilirubin (p 0.017*), alkaline phosphatase (p 0.022*), and gamma-glutamyl transferase (0.041*) were elevated. The results indicated that the CC genotype of TLR3 rs1879026 was associated with the development and chronicity of HCV infection compared to practically healthy individuals (p=0.001). In the distribution of genotypes and alleles for rs5743312, rs5743305, rs3775291, and rs5743311, no significant differences were found between patients with HCV and the healthy control group. Conclusion: The TLR3 rs1879026 gene polymorphism plays a significant role in the predisposition to HCV infection in the Kazakh population of the Aktobe and Atyrau regions.
Nurlanova, G., Zhumagaliyeva, G., Iskakova, A., Astrakhanov, A., & Kurmangazin, M. (2023). TLR3 Gene Polymorphism in HCV Infection in the Kazakh Population of Western Kazakhstan. Asian Pacific Journal of Cancer Prevention, 24(11), 3925-3930. doi: 10.31557/APJCP.2023.24.11.3925
MLA
Gulzhanat Nurlanova; Galina Zhumagaliyeva; Aigerim Iskakova; Akezhan Astrakhanov; Meirambek Kurmangazin. "TLR3 Gene Polymorphism in HCV Infection in the Kazakh Population of Western Kazakhstan". Asian Pacific Journal of Cancer Prevention, 24, 11, 2023, 3925-3930. doi: 10.31557/APJCP.2023.24.11.3925
HARVARD
Nurlanova, G., Zhumagaliyeva, G., Iskakova, A., Astrakhanov, A., Kurmangazin, M. (2023). 'TLR3 Gene Polymorphism in HCV Infection in the Kazakh Population of Western Kazakhstan', Asian Pacific Journal of Cancer Prevention, 24(11), pp. 3925-3930. doi: 10.31557/APJCP.2023.24.11.3925
VANCOUVER
Nurlanova, G., Zhumagaliyeva, G., Iskakova, A., Astrakhanov, A., Kurmangazin, M. TLR3 Gene Polymorphism in HCV Infection in the Kazakh Population of Western Kazakhstan. Asian Pacific Journal of Cancer Prevention, 2023; 24(11): 3925-3930. doi: 10.31557/APJCP.2023.24.11.3925
)